Fc Global Realty (OTCMKTS:FCRE) & NeurAxis (NASDAQ:NRXS) Critical Review

Fc Global Realty (OTCMKTS:FCRE) and NeurAxis (NASDAQ:NRXS) are both small-cap computer and technology companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, dividends, risk, earnings, profitability and valuation.

Insider & Institutional Ownership

11.8% of NeurAxis shares are held by institutional investors. 5.0% of Fc Global Realty shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Profitability

This table compares Fc Global Realty and NeurAxis’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Fc Global Realty	-4,265.28%	-24.94%	-9.42%
NeurAxis	-633.10%	N/A	-926.02%

Analyst Ratings

This is a summary of recent ratings and price targets for Fc Global Realty and NeurAxis, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Fc Global Realty	0	0	0	0	N/A
NeurAxis	0	0	1	0	3.00

Earnings & Valuation

This table compares Fc Global Realty and NeurAxis’ revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Fc Global Realty	$40,000.00	971.79	-$2.04 million	N/A	N/A
NeurAxis	$2.30 million	9.97	-$14.63 million	($3.73)	-0.92

Fc Global Realty has higher earnings, but lower revenue than NeurAxis.

Summary

NeurAxis beats Fc Global Realty on 5 of the 9 factors compared between the two stocks.

About Fc Global Realty

FC Global Realty Incorporated operates as a real estate investment company in the United States and internationally. It holds investments in various projects, such as high-end value hotels and resort communities; residential developments; and commercial properties, such as gas station sites. The company is based in Orangeburg, New York.

About NeurAxis

NeurAxis, Inc., a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 11-18 years of age with functional abdominal pain associated with irritable bowel syndrome. The company sells its products to healthcare companies, including hospitals and clinics. The company was formerly known as Innovative Health Solutions, Inc. and changed its name to NeurAxis, Inc. in March 2022. The company was founded in 2011 and is headquartered in Carmel, Indiana.